These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 2486539)

  • 1. Glomerular structures and lipids in progressive renal disease.
    Moorhead JF; Wheeler DC; Varghese Z
    Am J Med; 1989 Nov; 87(5N):12N-20N. PubMed ID: 2486539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipids and the progression of renal disease.
    Keane WF; O'Donnell MP; Kasiske BL; Schmitz PG
    J Am Soc Nephrol; 1990 Nov; 1(5 Suppl 2):S69-74. PubMed ID: 16989069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of lipids on glomerular injury and progression of renal disease.
    Keane WF
    Verh K Acad Geneeskd Belg; 1994; 56(2):91-104. PubMed ID: 8048270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipids and progression of renal disease: role of modified low density lipoprotein and lipoprotein(a).
    Wanner C; Greiber S; Krämer-Guth A; Heinloth A; Galle J
    Kidney Int Suppl; 1997 Dec; 63():S102-6. PubMed ID: 9407434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low density lipoproteins and mitogenic signal transduction processes: role in the pathogenesis of renal disease.
    Kamanna VS
    Histol Histopathol; 2002 Apr; 17(2):497-505. PubMed ID: 11962755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The renal toxicity of sustained glomerular protein traffic.
    Benigni A; Zoja C; Remuzzi G
    Lab Invest; 1995 Oct; 73(4):461-8. PubMed ID: 7474916
    [No Abstract]   [Full Text] [Related]  

  • 7. The glomerulus--a view from the inside--the endothelial cell.
    Fogo AB; Kon V
    Int J Biochem Cell Biol; 2010 Sep; 42(9):1388-97. PubMed ID: 20541032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High lipid levels in very low density lipoprotein and intermediate density lipoprotein may cause proteinuria and glomerulosclerosis in aging female analbuminemic rats.
    Joles JA; van Goor H; van der Horst ML; van Tol A; Elema JD; Koomans HA
    Lab Invest; 1995 Dec; 73(6):912-21. PubMed ID: 8558854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic implications of lipid-lowering agents in the progression of renal disease.
    Keane WF; Kasiske BL; O'Donnell MP; Schmitz PG
    Am J Med; 1989 Nov; 87(5N):21N-24N. PubMed ID: 2486540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of lipoproteins on the development and progression of renal disease.
    Dalrymple LS; Kaysen GA
    Am J Nephrol; 2008; 28(5):723-31. PubMed ID: 18434711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of increased glomerular protein traffic in the progression of renal failure.
    Bruzzi I; Benigni A; Remuzzi G
    Kidney Int Suppl; 1997 Nov; 62():S29-31. PubMed ID: 9350674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperlipidemia and progressive renal disease.
    Keane WF; Mulcahy WS; Kasiske BL; Kim Y; O'Donnell MP
    Kidney Int Suppl; 1991 Apr; 31():S41-8. PubMed ID: 2046270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraglomerular lipid deposition in renal disease.
    Lee HS; Lee SK
    Miner Electrolyte Metab; 1993; 19(3):144-8. PubMed ID: 8232101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Similarities between glomerular sclerosis and atherosclerosis in human renal biopsy specimens: a role for lipoprotein glomerulopathy.
    Avram MM
    Am J Med; 1989 Nov; 87(5N):39N-41N. PubMed ID: 2486545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interstitial foam cells and oxidized lipoprotein in human glomerular disease.
    Magil AB
    Mod Pathol; 1999 Jan; 12(1):33-40. PubMed ID: 9950160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progression of renal failure: role of apolipoprotein B-containing lipoproteins.
    Attman PO; Samuelsson O; Alaupovic P
    Kidney Int Suppl; 1997 Dec; 63():S98-101. PubMed ID: 9407433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of podocytes in glomerular pathobiology.
    Asanuma K; Mundel P
    Clin Exp Nephrol; 2003 Dec; 7(4):255-9. PubMed ID: 14712353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apoptosis in progressive crescentic glomerulonephritis.
    Shimizu A; Masuda Y; Kitamura H; Ishizaki M; Sugisaki Y; Yamanaka N
    Lab Invest; 1996 May; 74(5):941-51. PubMed ID: 8642789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The progression of renal disease.
    Klahr S; Schreiner G; Ichikawa I
    N Engl J Med; 1988 Jun; 318(25):1657-66. PubMed ID: 3287163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperlipidemia and renal disease: the use of animal models in understanding pathophysiology and approaches to treatment.
    Stevenson FT; Kaysen GA
    Wien Klin Wochenschr; 1999 Apr; 111(8):307-14. PubMed ID: 10378311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.